Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 100
Filter
1.
J Neonatal Perinatal Med ; 15(2): 243-247, 2022.
Article in English | MEDLINE | ID: mdl-35311715

ABSTRACT

BACKGROUND: Limited evidence exists on whether subclinical hypothyroidism suggested by mildly elevated TSH levels affect neurodevelopment and growth in preterm infants. The objective of this study was to determine the association between gestational age adjusted TSH percentiles and neurodevelopmental outcomes among preterm infants. METHODS: Univariate linear regression analysis was conducted to determine, in infants born less than thirty-two weeks gestational age, the correlation between the TSH percentile on the last newborn screen and neurodevelopmental assessment scores and growth outcomes at eighteen to twenty-two months of corrected age. RESULTS: Seventy-four patients were enrolled in the study with a mean gestational age of 28.8 weeks. There was no correlation between the last TSH percentile value and Bayley-III cognitive composite score or other neurodevelopmental or growth outcomes. CONCLUSION: In a cohort of preterm infants, higher TSH percentiles suggesting potential subclinical hypothyroidism did not predict any adverse effect on neurodevelopmental or growth outcomes.


Subject(s)
Hypothyroidism , Neurodevelopmental Disorders , Cohort Studies , Gestational Age , Humans , Hypothyroidism/diagnosis , Infant , Infant, Newborn , Infant, Premature , Neurodevelopmental Disorders/diagnosis , Thyrotropin
2.
Indian J Med Res ; 130(3): 266-76, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19901436

ABSTRACT

HPV infection in the genital tract is common in young sexually active individuals, the majority of whom clear the infection without overt clinical disease. However most of those who develop benign lesions eventually mount an effective cell mediated immune response and the lesions regress. Regression of ano-genital warts is accompanied histologically by a CD4+ T cell dominated Th1 response; animal models support this and provide evidence that the response is modulated by CD4+ T cell dependent mechanisms. Failure to develop effective CMI to clear or control infection results in persistent infection and, in the case of the oncogenic HPVs, an increased probability of progression to CIN3 and invasive carcinoma. The central importance of the CD4+ T cell population in the control of HPV infection is shown by the increased prevalence of HPV infections and HGSIL in individuals immunosuppressed as a consequence of HIV infection. The prolonged duration of infection associated with HPV seems to be associated with effective evasion of innate immunity as reflected in the absence of inflammation during virus replication, assembly and release, and down regulation of interferon secretion and response thus delaying the activation of adaptive immunity. Serum neutralising antibody to the major capsid protein L1 usually develops after the induction of successful cell mediated immunity and these antibody and cell mediated responses are protective against subsequent viral challenge in natural infections in animals. Prophylactic vaccines consisting of HPV L1 VLPs generate high anti L1 serum neutralizing antibody concentrations and in clinical trials have shown greater than 95 per cent efficacy against both benign and neoplastic genital HPV associated disease. These vaccines are delivered intramuscularly and therefore circumvent the immune evasion strategies of the virus.


Subject(s)
Papillomaviridae/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , Cross Protection , Cytotoxicity, Immunologic , Female , Humans , Immunity, Cellular , Immunity, Humoral , Interferons/metabolism , Male , Papillomaviridae/pathogenicity , Papillomavirus Infections/epidemiology , Papillomavirus Infections/immunology , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/pharmacology
3.
J Med Primatol ; 37(1): 45-54, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18199072

ABSTRACT

BACKGROUND: Individuals from an introduced population of longtail macaques on Mauritius have been extensively used in recent research. This population has low MHC gene diversity, and is thus regarded as a valuable resource for research. METHODS: We investigated the genetic diversity of this population using multiple molecular markers located in mitochondrial DNA and microsatellite DNA loci on the autosomes and the Y chromosome. We tested samples from 82 individuals taken from seven study sites. RESULTS AND CONCLUSIONS: We found this population to be panmictic, with a low degree of genetic variability. On the basis of an mtDNA phylogeny, we inferred that these macaques' ancestors originated from Java in Asia. Weak gametic disequilibrium was observed, suggesting decay of non-random associations between genomic genes at the time of founding. The results suggest that macaques bred in Mauritius are valuable as model animals for biomedical research because of their genetic homogeneity.


Subject(s)
Genetic Variation , Macaca fascicularis/genetics , Phylogeny , Animals , Base Sequence , Cluster Analysis , DNA, Mitochondrial/genetics , Mauritius , Microsatellite Repeats/genetics , Models, Genetic , Molecular Sequence Data , Polymorphism, Restriction Fragment Length , Sequence Analysis, DNA
4.
Psychol Med ; 38(3): 385-96, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17922939

ABSTRACT

BACKGROUND: Chronic obstructive pulmonary disease (COPD) affects 14 to 20 million Americans and is associated with increased prevalence of affective disorders, contributing significantly to disability. This study compared cognitive behavioral therapy (CBT) group treatment for anxiety and depression with COPD education for COPD patients with moderate-to-severe anxiety and/or depressive symptoms. METHOD: A randomized controlled trial (RCT) was conducted between 11 July 2002 and 30 April 2005 at the Michael E. DeBakey VA Medical Center, Houston, TX. Participants were 238 patients treated for COPD the year before, with forced expiratory value in 1 second (FEV)1/forced vital capacity (FVC)<70% and FEV1<70% predicted, and symptoms of moderate anxiety and/or moderate depression, who were being treated by a primary care provider or pulmonologist. Participants attended eight sessions of CBT or COPD education. Assessments were at baseline, at 4 and 8 weeks, and 4, 8 and 12 months. Primary outcomes were disease-specific and generic quality of life (QoL) [Chronic Respiratory Questionnaire (CRQ) and Medical Outcomes Survey Short Form-36 (SF-36) respectively]. Secondary outcomes were anxiety [Beck Anxiety Inventory (BAI)], depressive symptoms [Beck Depression Inventory-II (BDI-II)], 6-minute walk distance (6MWD) and use of health services. RESULTS: Both treatments significantly improved QoL, anxiety and depression (p<0.005) over 8 weeks; the rate of change did not differ between groups. Improvements were maintained with no significant change during follow-up. Ratios of post- to pretreatment use of health services were equal to 1 for both groups. CONCLUSIONS: CBT group treatment and COPD education can achieve sustainable improvements in QoL for COPD patients experiencing moderate-to-severe symptoms of depression or anxiety.


Subject(s)
Anxiety Disorders/therapy , Cognitive Behavioral Therapy/methods , Depressive Disorder/therapy , Patient Education as Topic/methods , Pulmonary Disease, Chronic Obstructive/psychology , Aged , Anxiety Disorders/diagnosis , Anxiety Disorders/epidemiology , Comorbidity , Depressive Disorder/diagnosis , Depressive Disorder/epidemiology , Female , Follow-Up Studies , Health Services/statistics & numerical data , Health Status , Humans , Male , Personality Inventory , Psychotherapy, Group/methods , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/therapy , Quality of Life , Surveys and Questionnaires , Texas/epidemiology , Treatment Outcome
5.
Biochem Soc Trans ; 35(Pt 6): 1456-60, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18031245

ABSTRACT

Infection with HPV (human papillomavirus) 16 is the cause of 50% or more of cervical cancers in women. HPV16 infection, however, is very common in young sexually active women, but the majority mount an effective immune response and clear infection. Approx. 10% of individuals develop a persistent infection, and it is this cohort who are at risk of cancer progression, with the development of high-grade precursor lesions and eventually invasive carcinoma. Effective evasion of innate immune recognition seems to be the hallmark of HPV infections, since the infectious cycle is one in which viral replication and release is not associated with inflammation. Furthermore, HPV infections disrupt cytokine expression and signalling with the E6 and E7 oncoproteins particularly targeting the type I IFN (interferon) pathway. High doses of IFN can overcome the HPV-mediated abrogation of signalling, and this may be the basis for the therapeutic effects on HPV infections of immune-response modulators such as the imidazoquinolones that induce high levels of type I IFNs by activation of TLR (Toll-like receptor) 7. Using the unique W12 model of cervical carcinogenesis, some of these IFN-related interactions and their relevance in the selection of cells with integrated viral DNA in cancer progression have been investigated. Our data show that episome loss associated with induction of antiviral response genes is a key event in the spontaneous selection of cervical keratinocytes containing integrated HPV16. Exogenous IFN-beta treatment of W12 keratinocytes in which the majority of the population contain episomes results only in the rapid emergence of IFN-resistant cells, loss of episome-containing cells and a selection of cells containing integrated HPV16 in which the expression of the transcriptional repressor E2 is down-regulated, but in which E6 and E7 are up-regulated.


Subject(s)
Human papillomavirus 16/immunology , Papillomavirus Infections/immunology , Uterine Cervical Neoplasms/immunology , Uterine Cervical Neoplasms/virology , Disease Progression , Female , Human papillomavirus 16/genetics , Humans , Interferon Type I/genetics , Interferon Type I/immunology , Oncogene Proteins, Viral/immunology , Signal Transduction/immunology , Toll-Like Receptor 7/immunology , Uterine Cervical Neoplasms/genetics , Virus Replication
6.
J Pathol ; 213(1): 27-34, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17642065

ABSTRACT

Integration of human papillomavirus type 16 (HPV16) is a common event in cervical carcinogenesis, although mechanisms of integration are poorly understood. We have tested the hypothesis that an increased number of DNA double-strand breaks (DSBs) affect HPV16 episome maintenance and integration in cervical keratinocytes. Increased DSBs were generated over prolonged periods of up to 50 population doublings in the unique polyclonal cervical keratinocyte cell line W12, which stably maintains HPV16 episomes. This was achieved using repeated treatments with short interfering RNA to obtain sustained depletion of Ku70, a key mediator of DNA non-homologous end joining. An increase in DSBs was seen shortly after commencement of Ku70 depletion. Continuous depletion was reproducibly associated with loss of HPV16 episomes and also with a new viral integration event, which was rapidly selected in outgrowing W12 cells. Despite the prolonged presence of DSBs, high-level chromosomal instability (detected by marked changes in genomic copy number) was not observed until cells containing the new integrant were almost fully selected, with no evidence of such chromosomal instability prior to integration. Our data show that increased DNA DSBs are associated with HPV16 episomal loss and integration in cervical keratinocytes. We found no evidence to support the notion that major chromosomal instability precedes HPV16 integration, although such instability is an important consequence of the integration event.


Subject(s)
Antigens, Nuclear/genetics , DNA Breaks, Double-Stranded , DNA-Binding Proteins/genetics , Gene Deletion , Human papillomavirus 16/genetics , Papillomavirus Infections/genetics , Virus Integration/physiology , Base Sequence , Cell Line, Tumor , Chromosomal Instability , DNA, Viral/genetics , Female , Genome, Viral , Human papillomavirus 16/physiology , Humans , In Situ Hybridization , Ku Autoantigen , Molecular Sequence Data , Polymerase Chain Reaction/methods , RNA Interference , RNA, Small Interfering/administration & dosage , Restriction Mapping , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/virology , Uterine Cervical Dysplasia/genetics , Uterine Cervical Dysplasia/virology
7.
Virchows Arch ; 443(1): 51-6, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12759751

ABSTRACT

We have used immunohistochemistry to test the hypothesis that components of the desmosome are disrupted during neoplastic progression of squamous epithelial cells in the uterine cervix. Sections of normal cervix and squamous intraepithelial lesions (SILs) were immunostained for desmosomal proteins and glycoproteins, and results were assessed using a semi-quantitative grading system. No difference between normal cervix and low-grade SIL (LSIL) was found. A significant reduction in expression of desmogleins was seen between high-grade SIL (HSIL) and LSIL (P<0.01) and normal cervix (P<0.001). Desmocollin expression was not reduced significantly, although scores showed significantly greater variation in HSIL compared with LSIL (P<0.05) and normal cervix (P<0.05). There was no significant difference in desmoplakin expression among the three groups. The results suggest that there may be sequential disruption of desmosomal function during neoplastic progression of cervical squamous intraepithelial cells, with downregulation of desmogleins during the progression from LSIL to HSIL and loss of desmocollin expression occurring in some cases of established HSIL.


Subject(s)
Cytoskeletal Proteins/metabolism , Desmosomes/metabolism , Uterine Cervical Dysplasia/metabolism , Uterine Cervical Neoplasms/metabolism , Biomarkers, Tumor/metabolism , Cytoskeletal Proteins/classification , Desmocollins , Desmogleins , Desmoplakins , Female , Humans , Immunoenzyme Techniques , Uterine Cervical Neoplasms/pathology , Uterine Cervical Dysplasia/pathology
8.
Int J Cancer ; 105(3): 326-30, 2003 Jun 20.
Article in English | MEDLINE | ID: mdl-12704665

ABSTRACT

S-phase kinase associated protein 2 (Skp2) is a member of the F-box family of substrate recognition subunits of SCF-ubiquitin ligase complexes and controls progression from G(1)-S-phase by targeting cell cycle regulators such as p21 and p27. Its locus is at 5p13, a region of frequent amplification in several cancers including carcinoma of the cervix (CaCx). Overexpression of Skp2 has been observed in many cancers of an advanced stage. We examine the expression of Skp2 in 42 invasive CaCx and its correlation with tumour differentiation state and p27 expression. Using immunohistochemistry we found increased nuclear expression of Skp2 in 55% of invasive CaCx cases analysed. It is significant that poorly differentiated tumours invariably exhibit high Skp2 expression (>40% positive nuclei), whereas well-differentiated tumours express Skp2 at a lower level (<20% positive nuclei). Skp2 expression in normal cervical epithelia is <10% (positive nuclei). Increased Skp2 protein levels did not correlate inversely with p27 expression. Our data suggest that Skp2 may contribute to the progression of CaCx, however, unlike non-human papillomavirus (HPV) containing tumours, p27 is unlikely to be the major target protein contributing to malignant progression. The high prevalence of HPV types in CaCx may circumvent the need for Skp2 to eliminate p27.


Subject(s)
Cell Cycle Proteins/biosynthesis , Microfilament Proteins/biosynthesis , Muscle Proteins , Uterine Cervical Neoplasms/metabolism , Cell Cycle , Cell Differentiation , Cell Nucleus/metabolism , Epithelial Cells/pathology , Female , Humans , Immunohistochemistry , Proto-Oncogene Proteins p21(ras)/metabolism , S-Phase Kinase-Associated Proteins
9.
Oncogene ; 22(16): 2531-40, 2003 Apr 24.
Article in English | MEDLINE | ID: mdl-12717429

ABSTRACT

The oncogenic HPVs immortalize primary genital keratinocytes in vitro and there is evidence that such lines represent suitable models to examine HPV-induced carcinogenesis. Early in vivo studies and more recent CGH analyses have revealed amplification of chromosome 5p in advanced stage carcinoma of the uterine cervix (CaCx). In the present study, a panel of established CaCx-derived cell lines were analysed by M-FISH to identify recurrent karyotypic abnormalities. Amplification of 5p was observed in 11 of 13 CaCx cell lines harbouring HR (high-risk) HPV. The region of 5p undergoing amplification was confirmed using human band-specific paints. The F-box protein Skp2 is present at 5p13 and its protein is present at increased levels in many cancers of an advanced stage. The HPV16-harbouring cell line W12 shows progressive morphological abnormality with in vitro passage, culminating in an invasive phenotype. The expression of Skp2 at different stages of this progression was investigated utilizing Western blot and TaqMan quantitative PCR. At medium to late passage, gain of 5p as an isochromosome was observed. Increased expression of Skp2 and a reduction in the expression of its target p27 correlated with increasing passage in this line.


Subject(s)
Cell Cycle Proteins/genetics , Chromosomes, Human, Pair 5 , Keratinocytes/metabolism , Cell Cycle Proteins/metabolism , Cell Line, Transformed , Cell Transformation, Viral/genetics , Chromosome Painting , Gene Amplification , Humans , In Situ Hybridization, Fluorescence , In Vitro Techniques , Papillomaviridae , Precipitin Tests , Proliferating Cell Nuclear Antigen/metabolism , S-Phase Kinase-Associated Proteins
10.
Clin Exp Dermatol ; 27(7): 571-7, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12464152

ABSTRACT

A central development of the past decade has been in our understanding of the interactions between, and interdependence of, the innate and adaptive immune responses. Innate immunity recognizes 'danger' signals and activates adaptive immunity in a targeted, appropriate and effective response. Dendritic cells and macrophages have a central role in this process, and pharmacological agents that modulate the functions of these cells could have therapeutic value. The imidazoquinolone compounds, of which imiquimod, formulated as Aldara trade mark, is the best characterized to date, are such molecules. Imiquimod and its homologues act by activating macrophages and other cells via binding to cell surface receptors, such as Toll receptor 7, thereby inducing secretion of pro-inflammatory cytokines, predominantly interferon (IFN)-alpha, tumour necrosis factor (TNF)-alpha and interleukin (IL)-12. This locally generated cytokine milieu biases towards a Th1 cell mediated immune response with the generation of cytotoxic effectors, and this has been exploited clinically in the treatment of viral infections (human papillomavirus, herpes simplex virus, molluscum contagiosum) and nonmelanoma skin cancer. Imiquimod has been shown to be significantly more effective than placebo in clearing genital warts, and mechanism of action studies indicate that this is related to the ability to generate proinflammatory cytokines and a Th1 response. Intra-epithelial neoplasms of cutaneous and mucosal surfaces are associated with human papillomavirus infection and there is some evidence that immune response modifiers may have therapeutic value for these lesions. Topical immunotherapy with immunomodulators shows potential for effective and patient-friendly treatment of cutaneous viral infections. These compounds also have adjuvant properties that could significantly enhance conventional vaccine strategies.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Aminoquinolines/therapeutic use , Skin Diseases/drug therapy , Adjuvants, Immunologic/pharmacology , Aminoquinolines/pharmacology , Animals , Disease Models, Animal , Humans , Imiquimod , Skin Neoplasms/drug therapy , Virus Diseases/drug therapy
11.
Behav Res Ther ; 40(11): 1305-15, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12384325

ABSTRACT

Affective correlates of hair pulling were investigated in a sample of 44 participants diagnosed with trichotillomania (TM). Participants completed the Hair Pulling Survey on which they rated the intensity of ten different affective states across three different phases of hair pulling (before, during and after). Repeated measures analysis of variance was used to examine the change of emotional experience across the hair pulling cycle. Results indicated significant decreases in boredom, anxiety and tension, and significant increases in guilt relief, sadness and anger across time (p<0.005). The role of co-existent anxiety and mood disorders also was examined using repeated measures analysis of variance. Results of these analyses indicated that patients with and without co-existent disorders differed only on patterns of anger across time, and therefore do not support affective subtypes of TM patients based on co-existent diagnosis. Implications of these findings for conceptualization and treatment of TM are discussed.


Subject(s)
Mood Disorders/psychology , Trichotillomania/etiology , Adolescent , Adult , Female , Humans , Incidence , Male , Trichotillomania/epidemiology
12.
J Gen Virol ; 83(Pt 9): 2299-2301, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12185285

ABSTRACT

In the canine oral papillomavirus (COPV) model, following wart regression, COPV DNA was detected by PCR at the challenge site. However, following particle-mediated immunotherapeutic delivery (PMID) of COPV L1 and subsequent challenge, no COPV DNA could be detected. These data support PMID of COPV L1 as a protective vaccine and suggest that PMID of L1 may induce virus clearance.


Subject(s)
DNA, Viral/analysis , Mouth Mucosa/virology , Papillomaviridae/immunology , Vaccines, DNA/administration & dosage , Viral Vaccines/administration & dosage , Warts/prevention & control , Administration, Buccal , Animals , Disease Models, Animal , Dogs , Papillomaviridae/genetics , Papillomaviridae/isolation & purification , Vaccination , Vaccines, DNA/therapeutic use , Viral Vaccines/therapeutic use , Warts/drug therapy , Warts/virology
13.
Am J Physiol Endocrinol Metab ; 281(6): E1165-71, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11701430

ABSTRACT

Biophysical forces regulate vascular smooth muscle cell (VSMC) physiology and evoke vascular remodeling. Two VSMC autocrine molecules, insulin-like growth factor I (IGF-I) and nitric oxide (NO), are implicated in remodeling attributable to VSMC hyperplasia. We investigated the role of in vitro cyclic stretch on rat VSMC IGF-I, NO, and cellular growth. Cyclic stretch (1 Hz at 120% resting length for 48 h) stimulated VSMC proliferation 2.5-fold vs. unstretched cells and was accompanied by a 1.8-fold increase in VSMC IGF-I secretion. Despite activation of this proliferative pathway, cyclic stretch induced inducible (i) nitric oxide synthase (NOS) expression and a twofold increase in NO secretion, a molecule with documented antiproliferative effects. Cytokine treatment enhanced iNOS expression and NO secretion while inhibiting vascular growth by approximately 50% in static cells. Cytokine treatment of stretched VSMC enhanced NO secretion 2.5-fold while inhibiting growth by approximately 80%. Exogenous IGF-I increased NOS activity 1.5-fold and NO secretion 8.5-fold in static cells. In turn, iNOS inhibition increased IGF-I secretion 1.6-fold and enhanced VSMC growth 1.6-fold in stretched cells. An NO donor (sodium nitroprusside) similarly inhibited VSMC proliferation in static (24%) and stretched (50%) VSMC while also inhibiting IGF-I secretion from stretched cells by approximately 35%. Thus cyclic stretch stimulates mitogenic (IGF-I) and antimitogenic (NO) pathways in VSMC. These two molecules regulate each other's secretory rates, providing tight regulation of VSMC proliferation. These data may have profound implications in understanding vascular growth alterations in vascular injury and hypertension.


Subject(s)
Mitosis/physiology , Muscle, Smooth, Vascular/cytology , Neovascularization, Physiologic/physiology , Animals , Blotting, Western , Cell Division/physiology , Cell Survival/physiology , Cells, Cultured , Culture Media, Conditioned , Cytokines/biosynthesis , Enzyme Inhibitors/pharmacology , Insulin-Like Growth Factor I/biosynthesis , Muscle, Smooth, Vascular/growth & development , Nitric Oxide/biosynthesis , Nitric Oxide/physiology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase Type II , Nitric Oxide Synthase Type III , Physical Stimulation , Rats , omega-N-Methylarginine/pharmacology
15.
Aging Ment Health ; 5(3): 269-74, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11575066

ABSTRACT

This study investigated worry content in older adults with and without generalized anxiety disorder (GAD). This is an important topic of research, where findings may promote improved recognition and treatment of this disorder in late-life, as well as provide information about the nature of worry across the lifespan. Worry content was compared for 44 older adults diagnosed with GAD and 44 normal control (NC) volunteers matched for age, gender, and ethnicity. Results indicated that older adults with GAD reported a wider variety of worry topics than did NC participants. However, there were no differences in worry content patterns between older adults with and without GAD. These results suggest that pathological worry in later life is not uniquely defined by content, and implications of these findings for assessment and treatment of GAD in older adults are discussed. Worry content reported by older adults also was compared with previously published younger adult worry content data. Age differences in worry content were found in both the clinical and non-clinical groups in patterns that were generally consistent with common age-related developmental changes. Directions for future research of worry across the lifespan are proposed.


Subject(s)
Anxiety Disorders/diagnosis , Geriatric Assessment , Activities of Daily Living/psychology , Adult , Aged , Aged, 80 and over , Anxiety Disorders/psychology , Female , Humans , Internal-External Control , Male , Middle Aged , Personality Assessment , Social Environment
16.
Psychol Assess ; 13(3): 347-55, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11556271

ABSTRACT

An array of measures of anxiety and related disorders (viz., Albany Panic and Phobia Questionnaire; Anxiety Sensitivity Index; Beck Anxiety Inventory; Beck Depression Inventory-II; Body Sensation Questionnaire; Fear Questionnaire; Padua Inventory; Penn State Worry Questionnaire; Post-Traumatic Stress Disorder Diagnostic Scale; Social Interaction Anxiety Inventory; and Worry Scale) was edited or translated from English into Spanish. Following an extensive edit and translation process, bilingual participants (n = 98) were assessed with the English and Spanish versions of these measures. Coefficient alphas were excellent and comparable across language versions. Means and standard deviations were also comparable across language versions. Evidence of convergent and discriminant validity was found for both language versions. The two language versions of each measure correlated highly with each other. This psychometric comparability adds confidence in using the newly edited or translated Spanish language measures in clinical practice and research.


Subject(s)
Anxiety/diagnosis , Mood Disorders/diagnosis , Personality Inventory/standards , Psychiatric Status Rating Scales/standards , Adult , Aged , Female , Hispanic or Latino/psychology , Humans , Male , Middle Aged , Psychometrics , Reproducibility of Results , Translations
17.
Best Pract Res Clin Obstet Gynaecol ; 15(5): 663-76, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11563866

ABSTRACT

Epidemiological studies show that infection with a subset of genital human papillomavirus (HPV) infections is the major risk factor for the subsequent development of cervical cancer. Experimental studies show that that the E6 and E7 genes of these high risk HPVs are oncogenes that deregulate key cell cycle controls. In the normal infectious cycle high level expression of these genes is confined to non-dividing differentiated cells: HPV oncogenesis requires deregulation of viral and cellular genes permitting inappropriate expression of E6 and E7. These are rare events but viral persistence and chronic exposure to steroid hormones increase the probability of this deregulation.


Subject(s)
Papillomaviridae , Papillomavirus Infections/complications , Repressor Proteins , Tumor Virus Infections/complications , Uterine Cervical Neoplasms/virology , Cell Cycle/genetics , Female , Humans , Oncogene Proteins, Viral/genetics , Papillomaviridae/genetics , Papillomavirus E7 Proteins , Papillomavirus Infections/epidemiology , Risk Factors , Tumor Virus Infections/epidemiology , Uterine Cervical Neoplasms/epidemiology
18.
Int J Gynecol Cancer ; 11(3): 187-93, 2001.
Article in English | MEDLINE | ID: mdl-11437923

ABSTRACT

Ionizing radiation has been used to treat cancers for a century. However, radioresistance remains a major problem in the clinic. Recent advances in the understanding of the molecular events that occur following ionizing radiation leading to DNA damage and repair, apoptosis, and cell cycle arrests suggest new ways in which the radiation response might be manipulated. Seventy-eight cases of carcinoma of the cervix of the same stage (II A and B) were analyzed retrospectively. All patients were treated with radiotherapy (RT) with a dose varying from 35 Gy to 50 Gy with 200 cGy per fraction. Subsequent to the completion of radiotherapy, all patients underwent surgery 4-6 weeks later. On histological examination of the surgical specimens, 51% of the cases (40) showed a complete response to therapy with no viable tumor cells. 49% of cases (38) had residual tumors ranging from a small focus to lesions extending through more than half the thickness of the cervical wall. p53 (mutant), bcl-2, p21 and bax proteins were studied on the paraffin sections of the biopsies (pretreatment) of those patients who failed to respond to RT and compared to similar studies on biopsies of patients who had a complete response to RT. In addition, the minichromosome maintenance (MCM) 2 proliferative marker was also done on all cases. Expression of all proteins was done using immunohistochemsitry. In the radioresistant cases, 15% (six cases) showed positivity for bcl-2 and p21, respectively, and 34% (13 cases) showed mutant p53. None of the radiosensitive tumors were positive for the above proteins. 75% of the radiosensitive tumors (30 cases) were positive for the bax antibody, whereas 81% of the radioresistant tumors (31 cases) were negative for bax. The MCM2 proliferative marker was positive in > 80% of cells in 81.5% of radioresistant tumors (31 cases) as compared to < 40% of cells that were positive in 70% of radiosensitive tumors (28 cases). The P-value for the biological markers was calculated using the chi-squared test, and was highly significant (P < 0.01) for all the parameters tested. However, there was no statistical significance by univariate analysis when the dose of radiation was analyzed with respect to the markers and the histological response. There was also no correlation between the radiation response and timing of surgery. The above data strongly suggest that bax, along with proliferative markers, could play a role in determining which tumors are likely to respond to radiation therapy. The presence of bcl-2, p21 and p53 could also be related to radioresistance of the tumors.


Subject(s)
Biomarkers, Tumor/metabolism , Biomarkers, Tumor/radiation effects , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/radiotherapy , Proto-Oncogene Proteins c-bcl-2 , Uterine Cervical Neoplasms/metabolism , Uterine Cervical Neoplasms/radiotherapy , Apoptosis Regulatory Proteins , Carrier Proteins/metabolism , Carrier Proteins/radiation effects , Female , Humans , Immunohistochemistry , Medical Records , Minichromosome Maintenance Complex Component 2 , Nuclear Proteins/metabolism , Nuclear Proteins/radiation effects , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins/radiation effects , Retrospective Studies , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor Protein p53/radiation effects , bcl-2-Associated X Protein , rho GTP-Binding Proteins/metabolism , rho GTP-Binding Proteins/radiation effects
19.
Psychol Med ; 31(4): 717-23, 2001 May.
Article in English | MEDLINE | ID: mdl-11352373

ABSTRACT

BACKGROUND: We hypothesized that compared to an educational intervention, a single 2 h session of cognitive behavioural therapy (CBT), with 6-week follow-up, would reduce anxiety and depression, improve physical and mental functioning, and lead to a better quality of life and greater satisfaction with treatment in older patients with chronic obstructive pulmonary disease (COPD). METHODS: Fifty-six subjects were recruited from a large, urban, academically affiliated Veterans Affairs (VA) Hospital, a non-profit private hospital, and a local newspaper, for a single blind randomized controlled clinical trial. One 2 h session of group CBT was designed to reduce symptoms of anxiety, with specific components including relaxation training, cognitive interventions, and graduated practice, followed by homework and weekly calls for 6 weeks. This was compared to a group that received 2 h of COPD education, followed by weekly calls. Pre- and post-intervention subjects in both groups were administered SF-36, Geriatric Depression Scale, Beck Anxiety Inventory, 6 min walk test, and the FEV-1. Following the intervention, both groups completed the Client Satisfaction Questionnaire. RESULTS: When compared with a group that received education about COPD, 2 h CBT group showed decreased depression and anxiety. Contrary to our hypothesis, despite the decrease in depression and anxiety, there was no change in the physical functioning of the patients. CONCLUSIONS: Twenty to 40% of patients with COPD have high levels of anxiety and depression. Our study finds that as little as 2 h of CBT administered in a group setting is able to reduce these anxious and depressive symptoms.


Subject(s)
Anxiety Disorders/therapy , Cognitive Behavioral Therapy , Depression/therapy , Lung Diseases, Obstructive/psychology , Aged , Anxiety Disorders/etiology , Depression/etiology , Female , Humans , Lung Diseases, Obstructive/complications , Male , Middle Aged , Patient Satisfaction , Quality of Life , Treatment Outcome , Urban Population
20.
Virology ; 284(1): 82-98, 2001 May 25.
Article in English | MEDLINE | ID: mdl-11352670

ABSTRACT

We studied experimental canine oral papillomavirus (COPV) infection by in situ hybridization and immunohistochemistry of weekly biopsies. After 4 weeks, viral DNA in rete ridges suggested a keratinocyte stem cell target. Abundant viral DNA was seen in E4-positive cells only. E4 was predominantly cytoplasmic but also nuclear, being concentrated in the nucleoli during wart formation. Infected cells spread laterally along the basal layer and into the parabasal layers, accompanied by E7 transcription and increased mitoses. Most of the lower epithelium was positive for viral DNA, but, in mature warts, higher levels of E4 expression and genome amplification occurred in only sporadic superficial cells. L1 expression was late and in only a subset of E4-positive cells. During regression, viral DNA was less abundant in deep epithelial layers, suggesting downregulation of replication prior to replacement of infected cells from beneath. Detection of viral DNA in post-regression tissue indicated latent infection.


Subject(s)
Capsid Proteins , DNA, Viral/isolation & purification , Keratinocytes/virology , Mouth Diseases/virology , Oncogene Proteins, Fusion/isolation & purification , Papillomaviridae/classification , Papillomavirus Infections/virology , Tumor Virus Infections/virology , Viral Proteins , Animals , Capsid/biosynthesis , DNA Replication , DNA, Viral/biosynthesis , DNA, Viral/chemistry , Disease Models, Animal , Dogs , Female , In Situ Hybridization , Mitotic Index , Mouth Mucosa/virology , Oncogene Proteins, Fusion/genetics , Open Reading Frames , Papillomaviridae/genetics , Papillomaviridae/physiology , RNA Probes , RNA, Viral/chemistry , Virus Latency
SELECTION OF CITATIONS
SEARCH DETAIL
...